ARCHIVES

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

This article is from The Cancer Letter archive.

Vol. 11 No. 14 | April 5, 1985

Download PDF Visit The Full Archive

Related Articles

DCT T Consider Reissuing RFA For Surgical Oncology

March 4, 1983

NIH Revitalization Act Authorizes $3 Billion For NCI In FY97

July 5, 1996

AACR Calls For Clear Statement; Says Report Was “Premature”

February 14, 1997

NCI Cooperative Group Clinical Trials Approved

April 30, 2010

Funding opportunities listed.

February 27, 2004

Lineberger Endows Chair To Honor Denman Hammond.

April 13, 2001